Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha.

Transactivation by c-Rel (nuclear factor kappaB) was dependent on phosphorylation of several serines in the transactivation domain, indicating that it is a phosphorylation-dependent Ser-rich domain. By Ser --> Ala mutational and deletion analysis, we have identified two regions in this domain: 1) a C-terminal region (amino acids 540-588), which is required for basal activity; and 2) the 422-540 region, which responds to external stimuli as tumor necrosis factor (TNF) alpha or phorbol myristate acetate plus ionomycin. Ser from 454 to 473 were shown to be required for TNFalpha-induced activation, whereas Ser between 492 and 519 were required for phorbol myristate acetate plus ionomycin activation. Phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) zeta were identified as downstream signaling molecules of TNFalpha-activation of c-Rel transactivating activity. Interestingly, dominant negative forms of PI3K inhibited PKCzeta activation and dominant negative PKCzeta inhibited PI3K-mediated activation of c-Rel transactivating activity, indicating a cross-talk between both enzymes. We have identified the critical role of different Ser for PKCzeta- and PI3K-mediated responses. Interestingly, those c-Rel mutants not only did not respond to TNFalpha but also acted as dominant negative forms of nuclear factor kappaB activation.

[1]  M. Fresno,et al.  Tumor Necrosis Factor-α Activation of NF-κB Requires the Phosphorylation of Ser-471 in the Transactivation Domain of c-Rel* , 2000, The Journal of Biological Chemistry.

[2]  W. Liao,et al.  Phosphatidylinositol 3-Kinase as a Mediator of TNF-Induced NF-κB Activation1 , 2000, The Journal of Immunology.

[3]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[4]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[5]  G. Stark,et al.  Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-κB p65/RelA Subunit , 1999, Molecular and Cellular Biology.

[6]  M. Palacín,et al.  Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-κB and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[7]  M. Diaz-Meco,et al.  The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.

[8]  A. Baldwin,et al.  Oncogenic Ras Enhances NF-κB Transcriptional Activity through Raf-dependent and Raf-independent Mitogen-activated Protein Kinase Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[9]  J. Anrather,et al.  Regulation of NF-κB RelA Phosphorylation and Transcriptional Activity by p21 ras and Protein Kinase Cζ in Primary Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[10]  A. Manning,et al.  Multiple signals converging on NF-κB , 1999 .

[11]  G. Bren,et al.  Activation of IκB Kinase β by Protein Kinase C Isoforms , 1999, Molecular and Cellular Biology.

[12]  Kendall A. Smith,et al.  c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. , 1999, International immunology.

[13]  C. Gélinas,et al.  Mapping of a Serine-Rich Domain Essential for the Transcriptional, Antiapoptotic, and Transforming Activities of the v-Rel Oncoprotein , 1999, Molecular and Cellular Biology.

[14]  D. Longo,et al.  Degradation of Proto-oncoprotein c-Rel by the Ubiquitin-Proteasome Pathway* , 1998, The Journal of Biological Chemistry.

[15]  A. Baldwin,et al.  Activation of Nuclear Factor-κB-dependent Transcription by Tumor Necrosis Factor-α Is Mediated through Phosphorylation of RelA/p65 on Serine 529* , 1998, The Journal of Biological Chemistry.

[16]  A. Newton,et al.  Regulation of protein kinase C ζ by PI 3-kinase and PDK-1 , 1998, Current Biology.

[17]  S. Ghosh,et al.  Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.

[18]  H. Handa,et al.  Functional Interference of Sp1 and NF-κB through the Same DNA Binding Site , 1998, Molecular and Cellular Biology.

[19]  S. Ghosh,et al.  Signal transduction through NF-κB , 1998 .

[20]  H. Handa,et al.  Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330. , 1998, Journal of immunology.

[21]  R. Farese,et al.  Protein Kinase C-ζ as a Downstream Effector of Phosphatidylinositol 3-Kinase during Insulin Stimulation in Rat Adipocytes , 1997, The Journal of Biological Chemistry.

[22]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[23]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[24]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[25]  H. Erdjument-Bromage,et al.  The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.

[26]  A. Strasser,et al.  Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Bren,et al.  Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes , 1996, Journal of virology.

[28]  M. Schmitz,et al.  Multi-Step Activation of NF-κB/Rel Transcription Factors , 1995 .

[29]  M. Schmitz,et al.  Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells. , 1995, The Journal of biological chemistry.

[30]  D. Fabbro,et al.  PKC zeta is a molecular switch in signal transduction of TNF‐alpha, bifunctionally regulated by ceramide and arachidonic acid. , 1995, The EMBO journal.

[31]  M. Meisterernst,et al.  Interaction of the COOH-terminal Transactivation Domain of p65 NF-κB with TATA-binding Protein, Transcription Factor IIB, and Coactivators (*) , 1995, The Journal of Biological Chemistry.

[32]  M. Fresno,et al.  Biphasic control of nuclear factor‐χB activation by the T cell receptor complex: role of tumor necrosis factor α , 1995 .

[33]  M. Czisch,et al.  Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. , 1994, The Journal of biological chemistry.

[34]  C. Scheidereit,et al.  Activation of NF‐kappa B in vivo is regulated by multiple phosphorylations. , 1994, The EMBO journal.

[35]  M. Karin.  Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. , 1994, Current opinion in cell biology.

[36]  T. Kanda,et al.  Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation. , 1993, Oncogene.

[37]  C. Gélinas,et al.  Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB , 1993, Molecular and cellular biology.

[38]  Qiang Zhou,et al.  Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB , 1993, Nature.

[39]  S. Hahn.  Structure(?) and function of acidic transcription activators , 1993, Cell.

[40]  M. Diaz-Meco,et al.  Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes , 1993, Molecular and cellular biology.

[41]  Dimitris Thanos,et al.  The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene , 1992, Cell.

[42]  J. Greenblatt.  Riding high on the TATA box , 1992, Nature.

[43]  T. Hunter,et al.  The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain , 1990, Molecular and cellular biology.

[44]  A. Israël,et al.  Purification of KBF1, a common factor binding to both H‐2 and beta 2‐microglobulin enhancers. , 1987, The EMBO journal.

[45]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[46]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[47]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .